SCHEMBL13805083

SCHEMBL13805083

c1ccc(-c2nnc(-c3ccc(N(c4ccccc4)c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3)n2-c2ccnc3ccccc23)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 2/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
AVPR1A P37288 1/20 0.36
MEN1 O00255 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
KCNH2 Q12809 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.34
OXTR P30559 1/20 0.34
ADRB2 P07550 1/20 0.33
NCF1 P14598 1/20 0.33
GLA P06280 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13805084 0.94 AKT1 (0.37) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL10110995 0.92 KDM4E (0.42) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL10111006 0.85 AKT1 (0.42) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL13805285 0.84 AVPR1A (0.48) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL1927315 0.84 KDM4E (0.50) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL13805328 0.84 AVPR1A (0.48) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL13805104 0.84 AVPR1A (0.48) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL1925079 0.83 KDM4E (0.49) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL13805102 0.83 KDM4E (0.39) HPGDSMN1; SMN2KDM4EATML3MBTL1
SCHEMBL13805095 0.83 HPGD (0.43) HPGDSMN1; SMN2KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8906518-B2 Triazole derivative, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-12-09 US disclosed
US-8906518-B2 Triazole derivative, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-12-09 US disclosed
US-20090160324-A1 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-06-25 US disclosed
US-20090160324-A1 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090160324-A1 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device GRIN3A, TEAD2, TBL3 HPGD 1843/4885SMN1; SMN2 4658/4885KDM4E 2154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.